Silvant Capital Management LLC Invests $12 Million in Axon Enterprise, Inc $AXON

Silvant Capital Management LLC bought a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 21,406 shares of the biotechnology company’s stock, valued at approximately $12,000,000.

A number of other hedge funds have also modified their holdings of the business. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the second quarter valued at $37,000. Creative Financial Designs Inc. ADV acquired a new position in Axon Enterprise during the fourth quarter valued at approximately $28,000. Camelot Portfolios LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter worth about $30,000. AlphaCentric Advisors LLC acquired a new stake in Axon Enterprise during the 4th quarter valued at $34,000. Finally, Strive Financial Group LLC acquired a new position in shares of Axon Enterprise in the 4th quarter valued at approximately $41,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on AXON. Barclays raised their price objective on Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. UBS Group upped their target price on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a report on Wednesday, July 22nd. Finally, Needham & Company LLC reissued a “buy” rating on shares of Axon Enterprise in a report on Thursday, August 6th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $730.92.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 13,000 shares of Axon Enterprise stock in a transaction on Friday, June 5th. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the completion of the sale, the president owned 169,125 shares of the company’s stock, valued at $82,609,106.25. This trade represents a 7.14% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the business’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total transaction of $753,690.00. Following the transaction, the insider owned 34,024 shares in the company, valued at approximately $16,501,640. This represents a 4.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 66,989 shares of company stock valued at $35,216,932 in the last 90 days. Corporate insiders own 4.20% of the company’s stock.

Axon Enterprise Price Performance

NASDAQ AXON opened at $614.26 on Friday. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $794.29. The stock’s 50-day moving average price is $539.39 and its two-hundred day moving average price is $475.81. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The company has a market cap of $49.90 billion, a PE ratio of 254.88, a PEG ratio of 10.48 and a beta of 1.39.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The firm had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company’s revenue was up 35.3% on a year-over-year basis. During the same quarter last year, the business posted $2.12 EPS. On average, analysts predict that Axon Enterprise, Inc will post 2.04 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.